PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
18-Nov-2024 Quell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy Program Quell Therapeutics
18-Nov-2024 BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations BrightHeart
18-Nov-2024 Update on Financial Position Celadon Pharmaceuticals Plc
18-Nov-2024 The King’s Fund calls on NHS leaders to help unlock power of industry partnerships ABPI
18-Nov-2024 iiCON funds 11 new innovative projects focused on tackling infectious diseases iiCON
18-Nov-2024 Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama® Formycon AG
18-Nov-2024 Better Mental Healthcare Outcomes for Implementing Patient-Engaging Solutions Research Nester
15-Nov-2024 Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA Formycon AG
15-Nov-2024 Quotient Sciences Announces Installation of World's First GMP Biofoundry-in-a-Box™ from Centillion Technology Quotient Sciences
15-Nov-2024 CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer Janssen-Cilag International NV
15-Nov-2024 AlveoGene Receives Rare Pediatric Disease Designation (RPDD) from FDA for AVG-002, its Novel, Inhaled Gene Therapy for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency AlveoGene
15-Nov-2024 Rippon Ubhi appointed Chair of the European Medicines Group Sanofi
15-Nov-2024 Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease Eisai
15-Nov-2024 Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Sanofi
15-Nov-2024 UK missing opportunity to unlock medicines for severe conditions ABPI
15-Nov-2024 Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations Biotest AG
14-Nov-2024 Comment on media report Evotec SE
14-Nov-2024 Abivax presents third quarter 2024 key financial information ABIVAX
14-Nov-2024 Aravax Establishes Pharmaceutical Development base on the Oxford Science Park with a Focus on Developing Manufacturing Capabilities in the UK Aravax
14-Nov-2024 Great Place To Work and Fortune Name Chiesi Group No. 23 in 2024 World’s Best Workplaces™ List Chiesi Group